Skip to main content

ProShare Advisors LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1357955 BETHESDA, MD

Position in GILD

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$357,426,219
+$104,996,070 QoQ
Shares Held
2,829,082
+56.2% QoQ
Ownership
0.228%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#57
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $1,455,266,466 across 11 Drug Manufacturers - General names. GILD ranks #1 (24.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GILD
Gilead Sciences, Inc.
This page
2,829,082 $357,426,219

All Filings in GILD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $357,426,219 2,829,082
2026-03-31 $252,430,149 1,811,223
2025-12-31 $272,150,174 2,217,290
2025-09-30 $176,882,718 1,593,538
2025-06-30 $215,749,250 1,945,966
2025-03-31 $207,615,540 1,852,883
2024-12-31 $152,105,494 1,646,698
2024-09-30 $119,209,832 1,421,873
2024-06-30 $92,394,822 1,346,667
2024-03-31 $108,482,297 1,480,987
2023-12-31 $98,616,875 1,217,342
2023-09-30 $107,259,823 1,431,276
2023-06-30 $97,591,891 1,266,276
2023-03-31 $110,455,554 1,331,271
2022-12-31 $104,732,106 1,219,943
2022-09-30 $85,185,623 1,380,866
2022-06-30 $100,856,056 1,631,711
2022-03-31 $144,370,341 2,428,433
2021-12-31 $185,525,738 2,555,099
2021-09-30 $124,775,918 1,786,341
2021-06-30 $111,313,704 1,616,522
2021-03-31 $105,768,933 1,636,530
2020-12-31 $82,476,002 1,415,654
2020-09-30 $77,340,136 1,223,930
2020-06-30 $79,452,091 1,032,650
2020-03-31 $66,925,899 895,210